Nursing CE / CME

Home About Contact Add Activities Provider Login

	Advances in Gene Therapy for Lysosomal Diseases This CME/CE activity highlights the current trends in gene therapy for lysosomal storage diseases as well as some of the safety concerns with such therapy. This activity provides continuing education credit for Physicians, Physician Assistants, Nurse Practitioners, Nurses, Genetic Counselors as well as a statement of participation for other participants. CheckRare
	Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer This case-based podcast presented by i3 Health brings together two leading experts, Anne Chiang, MD, PhD, Associate Professor of Medicine, and Henry Park, MD, MPH, Chief of the Thoracic Radiotherapy Program, both at Yale School of Medicine, who will examine recent clinical advances and new opportunities in the management of SCLC and discuss key clinical questions engendered by recent advances in treatment and the need for individualized care. Start the activity now. Statement of Need An ... i3 Health
	Novel Breast Cancer Therapies: Antibody-Drug Conjugates STATEMENT OF NEED Breast cancer is the most common cancer diagnosed in women, with an estimated 15% of cases being human epidermal growth factor receptor 2 (HER2)"positive and 12% being triple-negative (ACS, 2019). Antibody-drug conjugates have revolutionized the treatment of HER2-positive, triple-negative, and, most recently, HER2-low unresectable or metastatic breast cancer. These drugs combine a tumor antigen"targeted monoclonal antibody with a cytotoxic payload to permit the s... i3 Health
	Novel Breast Cancer Therapies: Immune Checkpoint Inhibitors STATEMENT OF NEED Breast cancer is the most common cancer diagnosed in women, and it is estimated that 12% of cases are classified as triple-negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) (ACS, 2019). Immune checkpoint inhibition in combination with chemotherapy is a new strategy in breast cancer, with the first immunotherapy approval for patients with advanced triple-negative disease occurring in 2019. Immune checkpoint inhibit... i3 Health
	Novel Breast Cancer Therapies: CDK4/6 Inhibitors STATEMENT OF NEED Breast cancer is the most common cancer diagnosed in women, with 287,850 new cases and 43,250 deaths predicted to occur in 2022 (ACS, 2022). Making up 73% of cases, hormone receptor (HR)"positive/human epidermal growth factor receptor 2 (HER2)"negative disease is the most common subtype of breast cancer (ACS, 2019). Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are a novel therapeutic option for patients with HR-positive, HER2-negative advanced breast cancer. T... i3 Health
	Novel Breast Cancer Therapies: HER2 Tyrosine Kinase Inhibitors STATEMENT OF NEED Breast cancer is the most common cancer diagnosed in women, and it is estimated that 15% of cases are HER2-positive and may therefore benefit from human epidermal growth factor receptor 2 (HER2) inhibition (ACS, 2019). By blocking downstream oncogenic signaling in HER2-positive breast cancer cells, HER2 tyrosine kinase inhibitors improve outcomes for patients with HER2-positive breast cancer. These agents have advantages over monoclonal antibody HER2 inhibitors because the... i3 Health
	Novel Breast Cancer Therapies: Monoclonal Antibodies STATEMENT OF NEED Breast cancer is the most common cancer diagnosed in women, and it is estimated that 15% of cases are human epidermal growth factor receptor 2 (HER2)"positive and may therefore benefit from HER2 inhibition (ACS, 2019). Monoclonal antibodies target HER2 function by preventing the formation or blocking the signaling of the oncogene HER2. The resulting loss of signaling downregulates oncogenic signaling in the cancer cell, resulting in improved clinical outcomes for pati... i3 Health
	Novel Breast Cancer Therapies: PARP Inhibitors STATEMENT OF NEED Breast cancer is the most commonly diagnosed cancer in women. A BRCA1 or BRCA2 mutation is found in approximately 5% of patients with breast cancer and is detected in 30% of patients who have a family history of breast or ovarian cancer (ACS, 2019). In patients with human epidermal growth factor receptor 2 (HER2)"negative breast cancer with deleterious or suspected deleterious germline BRCA mutations, inhibition of poly"(ADP-ribose) polymerase (PARP) is highly ef... i3 Health
	Novel Breast Cancer Therapies: PI3K Inhibitors STATEMENT OF NEED Breast cancer is the most diagnosed cancer in women, with hormone receptor (HR)"positive/human epidermal growth factor receptor 2 (HER2)"negative breast cancer being the most common subtype, making up 73% of cases (ACS, 2019). In breast cancer, phosphatidylinositol-3-kinase (PI3K) overactivation is often associated with an activating mutation in the catalytic alpha subunit of PI3K (PIK3CA). These activating mutations occur in more than one third of breast cancers... i3 Health
	PAH Research Highlights from CHEST PAH is a rare, progressive disorder characterized by high blood pressure in the pulmonary arteries. Symptoms of PAH include shortness of breath (dyspnea) especially during exercise, chest pain, and fainting episodes. The progressive nature of this disease means that an individual may experience only mild symptoms at first, but will eventually require treatment and medical care to maintain a reasonable quality of life. There are numerous treatment options and options in development for persons ... CheckRare
	Evolving Treatment Concepts and New Data in Advanced Prostate Cancer STATEMENT OF NEED Prostate cancer is the most common tumor type affecting men in the United States. It is estimated that 268,490 new cases were diagnosed and that 34,500 people died of prostate cancer in 2022 (Siegel et al, 2022). Prostate cancer alone accounts for 27% of all cancer diagnoses in men (ACS, 2022). To optimize outcomes for patients with prostate cancer, it is critical for health care providers to be familiar with the most recent evidence on therapy selection, biomarker testing... i3 Health
	Cracking the Code for Improved Patient Outcomes in Advanced Renal Cell Carcinoma STATEMENT OF NEED Renal cell carcinoma (RCC) comprises 2.4% of malignancies in adults worldwide (Makino et al, 2022). It is estimated that 79,000 new cases of kidney cancer were diagnosed in the US in 2022 (Siegel et al, 2022). RCC is characterized by a lack of early warning signs, diverse clinical manifestations, and resistance to radiation and chemotherapy. Several new therapies have been approved for RCC in recent years; therefore, it is important for the cancer care team to update their... i3 Health
	Oncology Data Advisor™: Aligning Treatment Goals and Value-Based Care in Newly Diagnosed Multiple Myeloma STATEMENT OF NEED Multiple myeloma is a clonal plasma cell malignancy characterized by several cytogenetic alterations. Treatment planning for individual patients is complicated by factors such as age, frailty, comorbidities, eligibility for autologous stem cell transplantation, and risk stratification (Kumar et al, 2022). Clinicians need to continually update their working knowledge of emerging data and consensus recommendations that can rationally inform clinical decision making. In Modul... i3 Health
	Virtual Tumor Board: Building Comprehensive Care Plans in Esophagogastric Cancers STATEMENT OF NEED Esophagogastric cancers include tumors of the esophagus, esophageal junction, and stomach. Esophageal cancers are the twentieth most commonly diagnosed cancer in the United States, but the eleventh leading cause of cancer death, with an estimated 21,560 cases diagnosed annually and 16,120 deaths estimated in 2023 (NCCN, 2023; Siegel et al, 2023). Given the poor prognosis of esophagogastric cancers and the complexity of personalized care planning, interdisciplinary teamwork... i3 Health
	Hitting the Target in HER2-Positive Metastatic Colorectal Cancer STATEMENT OF NEED An estimated 153,020 new cases of colorectal cancer (CRC) are diagnosed annually, and 52,550 people die of the disease (Siegel et al, 2023). Approximately 22% of patients present with metastatic disease, which is associated with a dismal 5-year survival rate of 15% (SEER, 2022). Targeting biomarkers is a key strategy for expanding therapeutic options and improving outcomes in metastatic CRC. Human epidermal growth factor receptor 2 (HER2) amplification status and treatment... i3 Health
	Building and Maintaining a Multidisciplinary Team for Lysosomal Disorders This CME/CE activity with Drs. Ozlem Goker-Aplan and Walla Al-Hertani describes the importance of a multidisciplinary team approach to managing lysosomal diseases, as well as some of the challenges involved in creating and maintaining that team. At the end of this activity, participants should be able to: - Describe the need for a team approach to care - Describe best practices to build a multidisciplinary team for a new patient - Describe best practices to maintain a multidisciplinary... CheckRare
	Myasthenia Gravis Research Highlights: AAN 2023 This 30-minute CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction. Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subtype of each patient as well as each patient’s comorbidities. There are currently four drugs approved by the FDA, eculizumab, efgartigimod, ravulizumab, and rozanolixizumab. There are also treatments in development. Clinical tria... CheckRare
	Leveraging the Growing Arsenal of Adjuvant Therapies for Early-Stage NSCLC In this activity, Dr. Helena A. Yu, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, will provide insights into strategies for leveraging the growing arsenal of adjuvant therapies for early-stage non"small cell lung cancer (NSCLC), including treatment selection and adverse event management. Start the activity now! STATEMENT OF NEED Lung cancer is the second most commonly diagnosed cancer and the leading cause of death for men and women worldwide. In the Unite... i3 Health
	Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer: Case Explorations and Answers to FAQs STATEMENT OF NEED Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for approximately 10% to 15% of breast cancer diagnoses and is characterized by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). TNBC is more common in Black women and in women under the age of 40 (ACS, 2023). Compared with other subtypes of invasive breast cancer, TNBC has high rates of metastasis and a poor prognosis. Due to the lack ... i3 Health
	Virtual Tumor Board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma STATEMENT OF NEED Sarcomas, which represent 1% to 2% of adult cancers, are a rare, heterogeneous group of neoplasms originating in the connective tissue. Soft tissue sarcomas, which begin in the muscle, tendons, fat, lymph, blood vessels, and nerves, encompass more than 80 histological subtypes. Approximately 25% of patients develop metastatic disease after curative-intent surgery, and for these patients, treatment options are limited and prognosis is very poor. In recent decades, the ident... i3 Health
	Putting the Freeze on Cold Agglutinin Disease STATEMENT OF NEED Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia (AIHA) in which antibodies cause hemolysis at cold temperatures, generally between 37º to 39º Fahrenheit. Approximately 1 in a million people are affected by CAD annually, with onset usually occurring between the ages of 40 and 80 years. Individuals commonly experience fatigue, dizziness, palpitations, and shortness of breath caused by the anemia; jaundice caused by degradation of hemoglobin i... i3 Health
	Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults STATEMENT OF NEED Acid sphingomyelinase deficiency (ASMD) is a rare, hereditary lysosomal storage disease with multisystemic manifestations, including splenomegaly, hepatomegaly, interstitial lung disease, dyslipidemia, bone marrow and lymph node involvement, and sometimes neurological and peripheral nerve involvement. While the most severe form of ASMD, infantile neurovisceral ASMD, results in death in early childhood, chronic forms of ASMD have more prolonged survival but are associated w... i3 Health
	Current Standards and New Directions in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura STATEMENT OF NEED Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life-threatening thrombotic microangiopathy with a rapid onset and progression and a mortality rate of 10% to 20% with prompt treatment. Onset of aTTP is characterized by severe thrombocytopenia, microangiopathic hemolytic anemia, and a constellation of associated symptoms including hemorrhage, neurologic and renal manifestations, cardiac abnormalities, and mesenteric ischemia (Joly et al, 2017). Survivors of f... i3 Health
	Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes STATEMENT OF NEED Head and neck cancers represent a heterogeneous group of tumors that originate in the lip/oral cavity, hypopharynx, oropharynx, nasopharynx, and larynx. An estimated 66,470 new cases are diagnosed in the United States annually, and 15,050 people die of the disease (Siegel et al, 2022). Approximately 90% of cases are classified as head and neck squamous cell carcinoma (HNSCC). Treatment of HNSCC is complicated by numerous factors, including differing therapeutic strategies ... i3 Health
	CCRN/PCCN Exam Review - Plattsburgh, NY This three-day course is designed to provide critical care and progressive care nurses a review of AACN’s core curriculum. The course combines central knowledge-based lectures so that nurses working in the PCU and ICU arena will have a review of AACN’s Certification Blueprint. The first day will provide the critical care provider with an essential review of nursing care and interventions designed for the ICU setting. The second day of this lecture series will combine both the critical care... MED-ED
	Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Treatments Target Audience This educational activity is directed toward dermatologists, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the treatment and management of HS. Primary care providers and women’s health professionals who may be involved in first-line diagnosis of HS are also invited to participate. Activity Overview This online educational activity is designed to provide an expert disease overview of hidradenitis suppurativa (HS... Physicians’ Education Resource®, LLC
	7th Annual National Hospitalist Conference The 7th Annual National Hospitalist Conference on October 3-6, 2023 at the Sheraton Denver Downtown Hotel is designed to provide attendees with the information and skills to improve the care of hospitalized patients. This conference has been accredited for up to 16 CME credits. The conference's focus is on the practical management of problems commonly encountered in hospital medicine. An emphasis will be placed on recent advances, up-to-date practices, and guidelines for inpatient care... Continuing Education Company
	Multidisciplinary Pelvic Health Update: From Population Health to Personalized Care Last year we ‘focused on function’ with an emphasis on metrics for measuring patient symptoms. This year our focus is on how to individualize treatments based on guidelines and population health, with an emphasis on algorithms of care that highlight the roles of the multidisciplinary teams in medical and surgical management. It will include three "supersessions" on defecatory disorder, urologic conditions, and pelvic pain management. Case and panel discussions between plenary spe... Virginia Mason Franciscan Health
	Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions. STATEMENT OF NEED Venous thromboembolism (VTE), which consists primarily of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold ... i3 Health
	Case Studies in Syphilis and Mpox: A STEP-HIV Initiative Members of the HIV care team are confronting two growing challenges"one old and one new. Syphilis rates reached a historic low in 2000/2001 but have since increased annually and have reached a disturbing trend nationally affecting all communities. People living with HIV (PLWH) are particularly vulnerable to this infection and its complications. Cases of human monkeypox virus (which is endemic to parts of western and central Africa), have risen steadily in the U.S. over the past few ... American Academy of CME
	Are You Up to Date on Your Flu Season Response? Flexing Your Clinical Management Muscles Influenza is a highly contagious seasonal viral infection that affects all age cohorts. While vaccination is still the best way to prevent influenza-associated illness, under-vaccination and other factors contribute to significant morbidity and mortality during influenza season. Timely use of influenza antiviral therapies can play a critical role in reducing disease severity, duration, and transmission, and therapy indications have recently expanded. Are You Up to Date on Your Flu Season Respo... Integritas Communications
	Splendors of Southern Europe Cruise: Exploring Medicine, Dentistry & the Mediterranean Healthcare Model Exploring Medicine, Dentistry & the Mediterranean Healthcare Model CME/CE Lecture Seminars for Medical, Dental, Nursing, and Allied Healthcare Professionals This Seminar is planned for 12 Continuing Education Credit Hours. CME/CE Professional Seminar Fee: $695 Seminar Attendance Fee: $450 CME/CE credits, Certificates of Completion and possible tax deductible guidelines will be provided for registered Professional Seminar attendees Certificates of Attendance will be provi... Professional Education Society
	Clinical Approaches to Obesity Management This goal of this remote webinar is to educate attendees about the therapeutic use and safety considerations with available treatment options for obesity in persons with and without diabetes. This program is accredited for a total of 2.0 contact hours (0.2 CEU) of continuing education credit. Learning objectives are provided below: Obesity in patients with diabetes: -Review clinical practice guidelines for the management of type 2 diabetes -Compare pharmacologic treatment options that pro... University of Pittsburgh School of Pharmacy
	Introduction to Abdominal and Primary Care Ultrasound Introduction to Abdominal & Primary Care Ultrasound Live Training Course is taught by leading abdominal and primary care ultrasound experts and covers liver, Gallbladder/biliary tree, renal/bladder, pancreas, spleen, abdominal aorta, GI tract, trauma, thyroid, scrotal, and soft-tissue applications. The abdominal and primary care ultrasound courses include lectures, interactive case presentations, and extensive hands-on skills training featuring the industry lowest 3:1 participant to facult... Gulfcoast Ultrasound Institute
	Nursing Management of Oral Mucositis Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions. STATEMENT OF NEED Oral mucositis (OM) is the inflammation of oral mucosa resulting from cancer therapy and manifesting as atrophy, swelling, erythema, and ulceration (Oronsky et al, 2018). Patients with OM may experience moderate-to-severe pain, difficulty speaking, difficulty eating and ... i3 Health
	Therapeutic Advancements for the Treatment of High-Risk MDS: Future Opportunities to Improve Patient Survival and Quality of Life Are you up to date on MDS? Engage with a leading oncology expert on recent changes in MDS classification and risk assessment of risk. Learn about emerging therapies for high-risk MDS and how they may impact clinical practice through case discussions. Do you have questions about the latest in MDS, such as: - What are the classifications of MDS? - What is the IPSS-M, and how do I use it to assess risk? - How should I manage patients with high-risk MDS? - What are the unmet needs for pa... The University of Texas MD Anderson Cancer Center
	Introduction to OB/GYN Ultrasound The Introduction to OB/GYN Ultrasound Live Training Course, taught by leading OB/GYN ultrasound experts, is a comprehensive course covering gynecological and 1st, 2nd, and 3rd trimester OB applications. Extensive hands-on skills training is provided with an industry low 3:1 participant to faculty ratio allowing the participant to immediately integrate the skills learned into clinical practice. Hands-on skills training includes transabdominal / transvaginal gynecological scan techniques and 2nd... Gulfcoast Ultrasound Institute
	13th Annual Primary Care Fall Conference Presented by Continuing Education Company for over 30 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. This year, the 13th Annual Primary Care Fall Conference is being held in person at the beautiful Hyatt Regency Maui on the island of Maui, Hawaii as well as via our virtual LIVE streaming webcast. Program Objectives As a result of thi... Continuing Education Company
	Diversity and Health Equity - From Discussion to Action Clinicians care for diverse patient populations whose physical and mental health and access to healthcare is differentially impacted by their race, sex, language, literacy, socioeconomic status, environmental exposures, and other unique factors. Our healthcare teams are similarly impacted by these factors. Ethnic minorities and patients of color experience widespread racism and discrimination in many aspects of life including housing, employment, and health care. A significant body of liter... Virginia Mason Franciscan Health
	Case Studies in Initial HIV Management: When, What, and How Antiretroviral therapy should be initiated for all persons with HIV immediately after (or as soon as possible after) an HIV diagnosis. HIV treatment guidelines are frequently updated and discuss optimal strategies for initiating antiretroviral therapy. Despite this support, it can still be challenging for the care team to start antiretroviral medications in a timely manner and select an optimal regimen that considers a patient’s unique health characteristics and social situations. Using a co... American Academy of CME
	Update CME: Internal Medicine and Primary Care Livestream Rebroadcast October 2023 This livestreamed conference (7.30 a.m. October 19 - 1.00 p.m. October 22) organized by the American Medical Forum will be a rebroadcast of the November 2022 conference. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers pre-recorded Q&A sessions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical ... American Medical Forum
	2023 Heart Failure Summit The 2023 Heart Failure Summit includes clinical presentation of Heart Failure, four pillars of optimal guideline-directed medical therapy, learn about the progression of advanced heart failure therapies, evaluation and treatment for patients with cardiomyopathies; Learn about minimally invasive procedures known to improve clinical outcomes of heart failure patients and much more topics. You can join in person or virtually. Opportunity to getting up to 7 AMA PRA Category 1 Credits. UC Davis Conference and Event Services
	Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making Target Audience This educational activity is directed toward neuromuscular specialists who treat patients with Pompe disease. Cardiologists, clinical geneticists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of Pompe disease are invited to participate. Program Overview Pompe disease is a genetic lysosomal storage disease"the first of these conditions to be identified"that is caused by deficiency of the... Physicians’ Education Resource®, LLC.
	Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It? Activity Overview This online, on-demand virtual symposium brings together experts on chronic kidney disease (CKD) in patients with diabetes. In this educational program, these experts discuss recent data regarding management of these patients, share their perspectives and best practices, and provide key insights specifically geared for nurse practitioners and physician assistants. This educational activity is an archive of the live virtual symposium held on September 9, 2022. Target Audie... Physicians’ Education Resource®, LLC,
	Emerging Strategies for Optimizing and Simplifying the Management of Resistant Hypertension Delve into emerging therapies for resistant hypertension in this symposium highlights video. Hear from a multidisciplinary panel of experts discussing the current state of evaluation, diagnosis, and management of resistant hypertension, along with the challenges faced by clinicians. A patient case study and panel discussion provide practical advice for improving patient outcomes within the evolving treatment landscape for a robust and engaging learning experience. ACHL
	Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care Activity Overview This online educational activity is designed to provide expert interpretation of new and emerging options for the prevention of migraine, with a forward-looking perspective on how migraine management for women can impact clinical practice of obstetrics and gynecology. Migraine pathophysiology, mitigating progression from episodic to chronic migraine, and topline clinical trial data for new and emerging agents targeting the calcitonin gene-related peptide pathway are among ke... Physicians’ Education Resource®, LLC.
	Perspective on PrEP: Connecting Communities & Clinicians Target Audience This activity is designed to meet the educational needs of clinicians currently treating people in the LGBTQ+ community. Program Overview We have made tremendous progress in treating HIV, but we still have an epidemic, with about 38,000 new HIV cases identified each year. Learn from expert faculty about how pre-exposure prophylaxis (PrEP) can virtually eliminate HIV, who is eligible for PrEP, and how to monitor patients using PrEP. You will also hear stories from people in... Postgraduate Institute for Medicine and DKBmed, LLC
	Burst CME: Regulatory Approval Pathways for Influenza Vaccines Target Audience This educational activity is directed toward geriatricians, primary care physicians, infectious disease physicians, internal medicine physicians, nurse practitioners, physician assistants, and nurses who manage older patients at risk for influenza. Program Overview This Burst CME: Regulatory Approval Pathways for Influenza Vaccines is an interview-based program in which an expert discusses the regulatory pathways for approval of influenza vaccines by the FDA. Licensure fro... Physicians’ Education Resource®, LLC.
	Evolving Recommendations and Strategies for Vaccine Selection in Populations at Risk for Severe Influenza-related Illness Are you current with the recent data and guidance on influenza vaccine selection based on age, risk factors, and individual characteristics? Do you know about the most recently approved and emerging vaccines? Access this comprehensive 60-minute, CME Touchpoint that will walk you through an overview of novel and emerging influenza vaccines and their potential roles in preventative medicine. This Touchpoint is enhanced with videos, graphics, and supplemental resources to provide you with the mos... ACHL
	Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older Target Audience This educational activity is directed toward geriatric medicine physicians, primary care physicians, infectious disease physicians, internal medicine physicians, NPs, PAs, and nurses who manage older patients at risk for influenza. Program Overview This Burst CME: Selecting an Appropriate Influenza Vaccine for Adults 65 Years and Older is an interview-based program in which an expert reviews the 3 quadrivalent influenza vaccines currently specified for older adults, with 2... Physicians’ Education Resource®, LLC.

«12 3 4 5 6 7 »

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map